# The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

> **NCT01727193** · PHASE3 · COMPLETED · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 290 (actual)

## Conditions studied

- Myasthenia Gravis

## Interventions

- **DRUG:** Azathioprine
- **DRUG:** Leflunomide

## Key facts

- **NCT ID:** NCT01727193
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2021-10-18
- **Final completion:** 2021-11-18
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01727193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01727193, "The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01727193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*